Brian Dunleavy

It can help inform appropriate antibiotic prescribing, but likely would only form part of testing protocol, experts say.

Greatest risk for infection among vaccinated may be at home rather than at work, researchers say.

Annals of Internal Medicine study shows move away from hydroxychloroquine to more proven therapies.

Study comparing mRNA shots finds variability in response, though both generally safe and effective.

New model uses syndromic surveillance to predict admissions related to SARS-CoV-2.

Study hoping to show reduced need for respiratory support with the approach failed to do so, though it does appear to limit the need for intubation.

Regimen reduces mortality and recovery time in patients severely ill with pneumonia caused by the virus.

Genetic sequencing can help assess how patient gut flora compares to donor both before and after FMT, study finds.

Commentary highlights importance, recommends steps to continuing surgical practice during pandemic.

Results from a study suggest that the effects of the virus on the brain may be more profound than respiratory symptoms.

“Higher-quality” evaluations of these technologies are “urgently needed,” researchers say.

A Letter to the Editor in Journal of Infection suggests findings to date may not be as positive as they appear.

A new study adds to growing concern about short immunity duration and the potential for reinfection.

COVID-19 patients require supervised pulmonary rehabilitation to recover ERS researchers say.

JAMA Internal Medicine study focused on patients with mild disease.

Analysis finds 2-day “lag” in case counts, potentially suggesting testing delays.

An estimate that 100K may have been infected by mid-March dwarfs official figures.

Drug has shown promise in COVID-19, but other, oral options are needed.

Symptomatic case fatality ratio and infection fatality ratio provide a more accurate picture of pandemic, they say.

Organizations believe the CDC is best positioned to collect, analyze and distribute information that is vital to research and response efforts.

Results highlight burden of disease and potential issues associated with contact tracing.

Efforts to develop a COVID-19 vaccine must not skip important steps during clinical evaluation, experts explain.

Black Americans bear a disproportional burden and negative outcomes from the coronavirus.

Analysis suggests approach may be particularly useful when testing resources are limited.

Findings reveal that most unhealthy seniors and/or their families opt for comfort-directed care rather than life-sustaining treatment.

Analysis projects significant toll from virus, even with some measures in place.

The only new drug approved for COVID-19 treatment has limited efficacy, but is still desperately needed to fight pandemic.

A new report outlines the proven steps needed to implement a national strategy for SARS-CoV-2 screening.

Findings of BMC Public Health analysis suggest cost-cutting measures may delay diagnosis and treatment.

A recent commentary calls for action to meet the mental health needs of patients and providers alike.